Form 8-K - Current report:
SEC Accession No. 0000950170-25-042005
Filing Date
2025-03-19
Accepted
2025-03-19 16:13:49
Documents
13
Period of Report
2025-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sera-20250319.htm   iXBRL 8-K 44399
2 EX-99.1 sera-ex99_1.htm EX-99.1 216367
3 GRAPHIC img88505028_0.jpg GRAPHIC 250432
  Complete submission text file 0000950170-25-042005.txt   724917

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sera-20250319.xsd EX-101.SCH 25838
15 EXTRACTED XBRL INSTANCE DOCUMENT sera-20250319_htm.xml XML 4904
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40606 | Film No.: 25752896
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)